Опыт комплексного применения модуляции сердечной сократимости устройством Optimizer Smart и эндоваскулярной реконструкции митрального клапана системой MitraClip в лечении сердечной недостаточности

На фоне оптимальной медикаментозной терапии пациентке 58 лет с тяжелой хронической сердечной недостаточностью и митральной регургитацией было имплантировано устройство Optimizer Smart для модуляции сердечной сократимости и проведена транскатетерная пластика митрального клапана с помощью системы MitraClip. Комплексная терапия привела к значительному клиническому улучшению и положительной динамике эхокардиографических показателей.

1. Braunwald’s heart disease: a textbook of cardiovascular medicine. 2-Volume Set 11th Edition. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, editors -Philadelphia, PA: Elsevier;2019. - 1944 p. ISBN 978-0-323-46342-3

2. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2019;21(10):1169–86. DOI: 10.1002/ejhf.1531

3. Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS et al. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. European Journal of Heart Failure. 2017;19(11):1414–23. DOI: 10.1002/ejhf.887

4. Терещенко С.Н., Романова Н.В., Жиров И.В., Осмоловская Ю.Ф., Голицын С.П. Российский регистр больных хронической сердечной недостаточностью и фибрилляцией предсердий (РИФ-ХСН): клинико-демографические характеристики выборки на момент включения в регистр. Журнал Сердечная Недостаточность. 2016;17(6):418–26. DOI: 10.18087/rhfj.2016.6.2276

5. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62(16):e147-239. DOI: 10.1016/j.jacc.2013.05.019

6. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al. Heart Disease and Stroke Statistics–2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–596. DOI: 10.1161/CIR.0000000000000757

7. Maddox TM, Januzzi JL, Allen LA, Breathett K, Butler J, Davis LL et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2021;77(6):772–810. DOI: 10.1016/j.jacc.2020.11.022

8. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/eurheartj/ehw128

9. Терещенко С.Н. Галявич А.С., Ускач Т.М., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л. и др. Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):311-74. DOI: 10.15829/1560-4071-2020-4083

10. Steffel J, Robertson M, Singh JP, Abraham WT, Bax JJ, Borer JS et al. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. European Heart Journal. 2015;36(30):1983–9. DOI: 10.1093/eurheartj/ehv242

11. Borggrefe M, Mann DL. Cardiac Contractility Modulation in 2018. Circulation. 2018;138(24):2738–40. DOI: 10.1161/CIRCULATIONAHA.118.036460

12. Salukhe TV, Henein MY, Sutton R. Ischemic Mitral Regurgitation and Its Related Risk After Myocardial Infarction. Circulation. 2005;111(3):254–6. DOI: 10.1161/01.CIR.0000154574.46566.D5

13. Grigioni F, Detaint D, Avierinos J-F, Scott C, Tajik J, Enriquez-Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. Journal of the American College of Cardiology. 2005;45(2):260–7. DOI: 10.1016/j.jacc.2004.10.030

14. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2017;38(36):2739–91. DOI: 10.1093/eurheartj/ehx391

15. Саидова М.А., Андрианова А.М. Ишемическая митральная недостаточность: алгоритм эхокардиографического обследования, место трехмерной чреспищеводной эхокардиографии. Кардиология. 2020;60(2):54-60. DOI: 10.18087/cardio.2020.2.n839

16. Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG et al. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients with Secondary Mitral Regurgitation: The COAPT Trial. Journal of the American College of Cardiology. 2019;74(24):2969–79. DOI: 10.1016/j.jacc.2019.09.017

17. Giustino G, Lindenfeld J, Abraham WT, Kar S, Lim DS, Grayburn PA et al. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial. JACC: Cardiovascular Interventions. 2020;13(20):2317–28. DOI: 10.1016/j.jcin.2020.06.058

18. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. American Heart Journal. 2007;154(2):260–6. DOI: 10.1016/j.ahj.2007.01.041

19. Rogers JK, Pocock SJ, McMurray JJV, Granger CB, Michelson EL, Östergren J et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. European Journal of Heart Failure. 2014;16(1):33–40. DOI: 10.1002/ejhf.29

20. York MK, Gupta DK, Reynolds CF, Farber-Eger E, Wells QS, Bachmann KN et al. B-Type Natriuretic Peptide Levels and Mortality in Patients with and Without Heart Failure. Journal of the American College of Cardiology. 2018;71(19):2079–88. DOI: 10.1016/j.jacc.2018.02.071

21. Porapakkham P. B-Type Natriuretic Peptide–Guided Heart Failure Therapy: A Meta-analysis. Archives of Internal Medicine. 2010;170(6):507–14. DOI: 10.1001/archinternmed.2010.35

22. Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. European Heart Journal. 2008;29(8):1019–28. DOI: 10.1093/eurheartj/ehn020

23. Abraham WT, Kuck K-H, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE et al. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC: Heart Failure. 2018;6(10):874–83. DOI: 10.1016/j.jchf.2018.04.010

24. Giallauria F, Vigorito C, Piepoli MF, Stewart Coats AJ. Effects of cardiac contractility modulation by non-excitatory electrical stimulation onexercise capacity and quality of life: An individual patient’s data metaanalysis of randomized controlled trials. International Journal of Cardiology. 2014;175(2):352–7. DOI: 10.1016/j.ijcard.2014.06.005

25. Wiegn P, Chan R, Jost C, Saville BR, Parise H, Prutchi D et al. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF5C2 Study. Circulation: Heart Failure. 2020;13(4):e006512. DOI: 10.1161/CIRCHEARTFAILURE.119.006512

26. Silbiger JJ. Novel Pathogenetic Mechanisms and Structural Adaptations in Ischemic Mitral Regurgitation. Journal of the American Society of Echocardiography. 2013;26(10):1107–17. DOI: 10.1016/j.echo.2013.07.003

27. Piérard LA, Lancellotti P. The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema. New England Journal of Medicine. 2004;351(16):1627–34. DOI: 10.1056/NEJMoa040532

28. Имаев Т.Э., Комлев А.Е., Кучин И.В., Акчурин Р.С. Транскатетерные методы в лечении патологии митрального клапана: современное состояние проблемы. Часть 1. Кардиологический вестник. 2020;15(1):4-13. DOI: 10.36396/MS.2020.16.1.001